Heat shock proteins (HSPs) derived from tumors or virally infected cells can stimulate antigen-specific CD8+ T cell responses in vitro and in vivo. Although this antigenicity is known to arise from HSP-associated peptides presented to the immune system by major histocompatibility complex (MHC) class I molecules, the cell biology underlying this presentation process remains poorly understood. Here we show that HSP 70 binds to the surface of antigen presenting cells by a mechanism with the characteristics of a saturable receptor system. After this membrane interaction, processing and MHC class I presentation of the HSP-associated antigen can occur via either a cytosolic (transporter associated with antigen processing [TAP] and proteasome–dependent) or an endosomal (TAP and proteasome–independent) route, with the preferred pathway determined by the sequence context of the optimal antigenic peptide within the HSP-associated material. These findings not only characterize two highly efficient, specific pathways leading to the conversion of HSP-associated antigens into ligands for CD8+ T cells, they also imply the existence of a mechanism for receptor-facilitated transmembrane transport of HSP or HSP-associated ligands from the plasma membrane or lumen of endosomes into the cytosol.
Skip Nav Destination
Article navigation
5 June 2000
Article|
June 06 1999
Receptor-Mediated Uptake of Antigen/Heat Shock Protein Complexes Results in Major Histocompatibility Complex Class I Antigen Presentation via Two Distinct Processing Pathways
Flora Castellino,
Flora Castellino
aLymphocyte Biology Section, Laboratory of Immunology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland 20892-1892
Search for other works by this author on:
Philip E. Boucher,
Philip E. Boucher
bDivision of Bacterial Products, Center for Biologics Evaluation and Research, U.S. Food and Drug Administration, Bethesda, Maryland 20892
Search for other works by this author on:
Katrin Eichelberg,
Katrin Eichelberg
aLymphocyte Biology Section, Laboratory of Immunology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland 20892-1892
Search for other works by this author on:
Mark Mayhew,
Mark Mayhew
cCellular Biochemistry and Biophysics Program, Memorial Sloan-Kettering Cancer Center, New York, New York 10021
Search for other works by this author on:
James E. Rothman,
James E. Rothman
cCellular Biochemistry and Biophysics Program, Memorial Sloan-Kettering Cancer Center, New York, New York 10021
Search for other works by this author on:
Alan N. Houghton,
Alan N. Houghton
dDepartment of Medicine and the Immunology Program, Memorial Sloan-Kettering Cancer Center, New York, New York 10021
Search for other works by this author on:
Ronald N. Germain
Ronald N. Germain
aLymphocyte Biology Section, Laboratory of Immunology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland 20892-1892
Search for other works by this author on:
Flora Castellino
aLymphocyte Biology Section, Laboratory of Immunology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland 20892-1892
Philip E. Boucher
bDivision of Bacterial Products, Center for Biologics Evaluation and Research, U.S. Food and Drug Administration, Bethesda, Maryland 20892
Katrin Eichelberg
aLymphocyte Biology Section, Laboratory of Immunology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland 20892-1892
Mark Mayhew
cCellular Biochemistry and Biophysics Program, Memorial Sloan-Kettering Cancer Center, New York, New York 10021
James E. Rothman
cCellular Biochemistry and Biophysics Program, Memorial Sloan-Kettering Cancer Center, New York, New York 10021
Alan N. Houghton
dDepartment of Medicine and the Immunology Program, Memorial Sloan-Kettering Cancer Center, New York, New York 10021
Ronald N. Germain
aLymphocyte Biology Section, Laboratory of Immunology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland 20892-1892
Abbreviations used in this paper: ER, endoplasmic reticulum; HSP, heat shock protein; TAP, transporter associated with antigen processing.
M. Mayhew's present address is Mojave Therapeutics, Inc., Tarrytown, NY 10591.
Received:
December 06 1999
Revision Requested:
April 03 2000
Accepted:
April 04 2000
Online ISSN: 1540-9538
Print ISSN: 0022-1007
© 2000 The Rockefeller University Press
2000
The Rockefeller University Press
J Exp Med (2000) 191 (11): 1957–1964.
Article history
Received:
December 06 1999
Revision Requested:
April 03 2000
Accepted:
April 04 2000
Citation
Flora Castellino, Philip E. Boucher, Katrin Eichelberg, Mark Mayhew, James E. Rothman, Alan N. Houghton, Ronald N. Germain; Receptor-Mediated Uptake of Antigen/Heat Shock Protein Complexes Results in Major Histocompatibility Complex Class I Antigen Presentation via Two Distinct Processing Pathways. J Exp Med 5 June 2000; 191 (11): 1957–1964. doi: https://doi.org/10.1084/jem.191.11.1957
Download citation file:
Sign in
Don't already have an account? Register
Client Account
You could not be signed in. Please check your email address / username and password and try again.
Could not validate captcha. Please try again.
Sign in via your Institution
Sign in via your InstitutionSuggested Content
Email alerts
Advertisement